1. Home
  2. VHC vs PYPD Comparison

VHC vs PYPD Comparison

Compare VHC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$12.86

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.76

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
PYPD
Founded
2005
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
85.1M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
VHC
PYPD
Price
$12.86
$4.76
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$12.25
AVG Volume (30 Days)
18.4K
131.8K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
0.99
N/A
EPS
N/A
N/A
Revenue
$162,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3140.00
N/A
52 Week Low
$7.51
$3.06
52 Week High
$29.00
$5.21

Technical Indicators

Market Signals
Indicator
VHC
PYPD
Relative Strength Index (RSI) 40.27 53.23
Support Level $11.51 $4.18
Resistance Level $18.38 $5.09
Average True Range (ATR) 1.26 0.29
MACD -0.26 -0.01
Stochastic Oscillator 19.94 41.98

Price Performance

Historical Comparison
VHC
PYPD

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: